Tackling COVID-19 with neutralizing monoclonal antibodies

Giovedì 10 giugno 2021 circa 1 minuti di lettura

Journal and Affiliations:

Cell, 10 giugno 2021

Davide Corti, Humabs BioMed, Bellinzona

Tags:
COVID-19
monoclonal antibody
neutralization
SARS-CoV-2
therapeutics
Authors:
Davide Corti
Link: https://www.cell.com/cell/fulltext/S0092-8674(21)00602-4?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0092867421006024%3Fshowall%3Dtrue